OSR Holdings, Inc.

As a global healthcare holding company, the company operates with a presence in South Korea, Switzerland, and an office in the United States. It aims to identify, lead, and support the growth of its subsidiaries and potential subsidiary candidates, which are either existing entities or new companies formed through acquiring or licensing assets from industry or academia. The company focuses on innovative research and seeks to pair teams with pharmaceutical or medical device technologies that have the potential to treat diseases and improve healthcare outcomes, providing them with financial and other resources. It evaluates subsidiary candidate opportunities by understanding target indications to identify new approaches and technologies for improved treatment outcomes. The company collaborates with academic and industry leaders, integrating entrepreneurial scientists with business development and leadership teams. Its leadership team supports subsidiaries in transforming discoveries into commercial products. The company's expertise comes from industry veterans, scientists, capital market, and legal professionals. It operates a hub-and-spoke business model, with a centralized executive team partnering with subsidiary management teams to ensure program and corporate alignment.